NCT04692389 2022-02-08
Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.
Welcare Industries SpA
Phase NA Withdrawn
Welcare Industries SpA
Sorrento Therapeutics, Inc.
Boston Scientific Corporation
Flowonix Medical
Hoffmann-La Roche
9305-9954 Quebec Inc
Cristália Produtos Químicos Farmacêuticos Ltda.